本页面由Tiger Trade Technology Pte. Ltd.提供服务

Anebulo Pharmaceuticals, Inc.

0.4650
-0.0099-2.08%
成交量:1.65万
成交额:7,737.03
市值:1,910.44万
市盈率:-2.07
高:0.4725
开:0.4665
低:0.4650
收:0.4749
52周最高:3.42
52周最低:0.4351
股本:4,108.47万
流通股本:340.13万
量比:0.14
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-0.2245
每股收益(LYR):-0.2509
净资产收益率:-145.11%
总资产收益率:-86.11%
市净率:1.96
市盈率(LYR):-1.85

数据加载中...

2026/02/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

重要事件披露

Form 8-K - Current report
2026/02/06

重要事件披露

Form 8-K - Current report
2026/01/29

重要事件披露

Form 8-K - Current report
2026/01/27

私有化交易

Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
2026/01/27

重要事件披露

Form 8-K - Current report
2025/12/22

私有化交易

Form SC TO-I - Tender offer statement by Issuer
2025/12/22

重要事件披露

Form 8-K - Current report
2025/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/14

重要事件披露

Form 8-K - Current report
2025/10/11

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2025/09/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/09/29

重要事件披露

Form 8-K - Current report
2025/09/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/26

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/09/15

私有化交易

Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
2025/09/12

重要事件披露

Form 8-K - Current report
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/23

私有化交易

Form SC 13E3 - Going private transaction by certain issuers
2025/05/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans